UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 8.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 120,868 shares of the company's stock after selling 10,732 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.37% of Bowhead Specialty worth $4,293,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company lifted its stake in Bowhead Specialty by 0.8% during the fourth quarter. The Manufacturers Life Insurance Company now owns 60,963 shares of the company's stock worth $2,165,000 after purchasing an additional 455 shares during the last quarter. Summit Investment Advisors Inc. lifted its stake in Bowhead Specialty by 66.4% during the fourth quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock worth $43,000 after purchasing an additional 486 shares during the last quarter. Sei Investments Co. lifted its stake in Bowhead Specialty by 0.8% during the fourth quarter. Sei Investments Co. now owns 94,395 shares of the company's stock worth $3,353,000 after purchasing an additional 760 shares during the last quarter. Schroder Investment Management Group lifted its stake in Bowhead Specialty by 0.3% during the fourth quarter. Schroder Investment Management Group now owns 365,886 shares of the company's stock worth $12,641,000 after purchasing an additional 1,209 shares during the last quarter. Finally, New York State Common Retirement Fund bought a new position in Bowhead Specialty during the fourth quarter worth $64,000.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on BOW. JMP Securities raised their price objective on Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a research note on Friday, April 11th. Keefe, Bruyette & Woods raised their price objective on Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a research note on Friday, May 9th. Morgan Stanley raised their target price on Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Piper Sandler assumed coverage on Bowhead Specialty in a research note on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 target price on the stock. Finally, JPMorgan Chase & Co. raised their target price on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $39.67.
View Our Latest Stock Analysis on Bowhead Specialty
Bowhead Specialty Stock Up 0.8%
BOW stock traded up $0.28 during mid-day trading on Friday, reaching $36.30. The company had a trading volume of 137,919 shares, compared to its average volume of 198,609. The stock has a market capitalization of $1.19 billion and a P/E ratio of 27.71. Bowhead Specialty Holdings Inc. has a one year low of $23.70 and a one year high of $42.29. The stock's 50-day simple moving average is $38.80 and its two-hundred day simple moving average is $36.06.
Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.01. The company had revenue of $174.85 million during the quarter, compared to the consensus estimate of $105.17 million. On average, research analysts forecast that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current fiscal year.
About Bowhead Specialty
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Stories

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.